Answers are grounded in this paper and cite their sources.
Case report shows improved quality of life in a patient with fibrocalculous pancreatic diabetes after switching to a closed-loop insulin pump, suggesting better diabetes management.
Fibrocalculous pancreatic diabetes (FCPD) is a rare form of secondary diabetes in which there is insulin deficiency. The mainstay of treatment for FCPD is insulin. When insulin is delivered through basal bolus regime, there is a risk of hypo and hyperglycemic episodes if the dose is not adjusted properly. In this case, we report the journey of a patient with FCPD who was earlier on basal bolus insulin regime and later switched to the automated hybrid closed-loop 780G insulin pump, which significantly improved her quality of life.
No takes yet. Share an insight, caveat, or question.
Damle et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: